Advisor Group Holdings, Inc. Ascendis Pharma A/S Transaction History

Advisor Group Holdings, Inc.

$42.2 Billion
Q3 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 773 shares of ASND stock, worth $103,798. This represents 0.0% of its overall portfolio holdings.

Number of Shares

773

Previous 379 103.96%

Holding current value

$103,798

Previous $51,000 125.49%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$113.0 - $153.43 $44,522 - $60,451	394 Added 103.96%	773 $115,000
Q2 2024 Aug 13, 2024	SELL	$121.07 - $153.67 $1.45 Million - $1.84 Million	-11,946 Reduced 96.92%	379 $51,000
Q1 2024 May 10, 2024	BUY	$123.45 - $159.4 $1.41 Million - $1.83 Million	11,456 Added 1318.3%	12,325 $1.86 Million
Q4 2023 Feb 12, 2024	SELL	$86.1 - $127.36 $25,227 - $37,316	-293 Reduced 25.22%	869 $109,000
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $10,553 - $12,684	-122 Reduced 9.5%	1,162 $108,000
Q2 2023 Aug 10, 2023	BUY	$69.96 - $97.84 $18,679 - $26,123	267 Added 26.25%	1,284 $114,000
Q1 2023 May 12, 2023	BUY	$104.9 - $126.78 $16,259 - $19,650	155 Added 17.98%	1,017 $109,000
Q4 2022 Feb 10, 2023	SELL	$99.42 - $131.97 $8,649 - $11,481	-87 Reduced 9.17%	862 $105,000
Q3 2022 Nov 14, 2022	BUY	$84.03 - $110.23 $6,554 - $8,597	78 Added 8.96%	949 $99,000
Q2 2022 Aug 10, 2022	BUY	$78.08 - $117.61 $17,177 - $25,874	220 Added 33.79%	871 $81,000
Q1 2022 May 04, 2022	SELL	$102.18 - $135.75 $135,797 - $180,411	-1,329 Reduced 67.12%	651 $76,000
Q3 2021 Nov 05, 2021	SELL	$112.67 - $176.92 $12,957 - $20,345	-115 Reduced 5.49%	1,980 $315,000
Q2 2021 Aug 02, 2021	SELL	$121.62 - $145.29 $2,067 - $2,469	-17 Reduced 0.8%	2,095 $275,000
Q1 2021 May 13, 2021	BUY	$124.92 - $173.33 $33,853 - $46,972	271 Added 14.72%	2,112 $272,000
Q4 2020 Feb 10, 2021	BUY	$151.2 - $182.76 $16,934 - $20,469	112 Added 6.48%	1,841 $308,000
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $43,509 - $49,999	324 Added 23.06%	1,729 $266,000
Q2 2020 Aug 14, 2020	BUY	$110.87 - $156.01 $144,352 - $203,125	1,302 Added 1264.08%	1,405 $207,000
Q1 2020 May 18, 2020	BUY	$97.01 - $145.11 $9,992 - $14,946	103 New	103 $11,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.49B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Ascendis Pharma A/S Transaction History